EMPAYES-25 (Empagliflozin 25 mg)

MOA

1. Inhibits SGLT2 in kidneys
2. Increases glucose excretion
3. Reduces blood glucose
4. Promotes weight loss
5. Lowers blood pressure
6. Reduces cardiovascular risk
7. Protects kidney function

Uses

1. Type 2 diabetes
2. Cardiovascular risk reduction
3. Heart failure
4. Diabetic kidney disease
5. Obese diabetic patients
6. Glycemic control
7. Long-term diabetes management

Side Effects

1. Urinary infections
2. Genital infections
3. Increased urination
4. Dehydration
5. Hypotension
6. Dizziness
7. Ketoacidosis (rare)

Precautions

1. Maintain hydration
2. Monitor renal function
3. Avoid in severe kidney disease
4. Watch for infections
5. Monitor BP
6. Avoid in type 1 diabetes
7. Use under supervision

Tags: Empagliflozin 25 mg